These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15901053)

  • 41. Aqueous Leaf Extract of Withania somnifera as a Potential Neuroprotective Agent in Sleep-deprived Rats: a Mechanistic Study.
    Manchanda S; Mishra R; Singh R; Kaur T; Kaur G
    Mol Neurobiol; 2017 May; 54(4):3050-3061. PubMed ID: 27037574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
    Mu X; He G; Cheng Y; Li X; Xu B; Du G
    Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease.
    Quintero EM; Willis L; Singleton R; Harris N; Huang P; Bhat N; Granholm AC
    Brain Res; 2006 Jun; 1093(1):198-207. PubMed ID: 16712819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model.
    Gören B; Mimbay Z; Bilici N; Zarifoğlu M; Oğul E; Korfali E
    Turk Neurosurg; 2009 Jul; 19(3):230-6. PubMed ID: 19621286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
    Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
    Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Withania somnifera (L.) Dunal aqueous root extract on reinstatement using conditioned place preference and brain GABA and dopamine levels in alcohol dependent animals.
    Marathe PA; Satam SD; Raut SB; Shetty YC; Pooja SG; Raut AA; Kale PP; Rege NN
    J Ethnopharmacol; 2021 Jun; 274():113304. PubMed ID: 32920131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson's disease.
    García JC; Remires D; Leiva A; González R
    J Mol Neurosci; 2000 Jun; 14(3):147-53. PubMed ID: 10984190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
    Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study.
    Kasture S; Vinci S; Ibba F; Puddu A; Marongiu M; Murali B; Pisanu A; Lecca D; Zernig G; Acquas E
    Neurotox Res; 2009 Nov; 16(4):343-55. PubMed ID: 19551457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Kumari R; Kumar JB; Luthra PM
    Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.
    Afshin-Majd S; Khalili M; Roghani M; Mehranmehr N; Baluchnejadmojarad T
    Mol Neurobiol; 2015; 51(3):1064-70. PubMed ID: 24939694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.
    Carmo MR; Menezes AP; Nunes AC; Pliássova A; Rolo AP; Palmeira CM; Cunha RA; Canas PM; Andrade GM
    Neuropharmacology; 2014 Jun; 81():142-52. PubMed ID: 24508709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action.
    Naidu PS; Singh A; Kulkarni SK
    J Med Food; 2003; 6(2):107-14. PubMed ID: 12935321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.
    RajaSankar S; Manivasagam T; Sankar V; Prakash S; Muthusamy R; Krishnamurti A; Surendran S
    J Ethnopharmacol; 2009 Sep; 125(3):369-73. PubMed ID: 19666100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective Effect of CR-777, a Glutathione Derivative of Withaferin A, Obtained through the Bioconversion of
    Rabhi C; Arcile G; Le Goff G; Da Costa Noble C; Ouazzani J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31888204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephroprotective effect of Withania somnifera: a dose-dependent study.
    Jeyanthi T; Subramanian P
    Ren Fail; 2009; 31(9):814-21. PubMed ID: 19925290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
    Jin F; Wu Q; Lu YF; Gong QH; Shi JS
    Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
    Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.
    Ozsoy O; Yildirim FB; Ogut E; Kaya Y; Tanriover G; Parlak H; Agar A; Aslan M
    Free Radic Res; 2015; 49(8):1004-14. PubMed ID: 25791066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.